FDA Inspection 672552 — Omega Biological Laboratories Inc.

Omega Biological Laboratories Inc. — FEI 3002864704

The FDA completed an inspection of Omega Biological Laboratories Inc. on July 9, 2010 in Lyndhurst, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 9, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lyndhurst, NJ (United States)

Citations

IDCFRDescription
113321 CFR 211.25(a)GMP Training Frequency
117721 CFR 211.63Equipment Design, Size and Location
181021 CFR 211.160(a)Lab controls established, including changes
203421 CFR 211.194(d)Laboratory equipment calibration records